Clinical Trial Update: Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating carboplatin and pemetrexed in recurrent platinum-sensitive ovarian cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Ovarian Cancer, Peritoneal Cancer | Phase 2 | Status: COMPLETED